Dashboard PDUFA PDUFA History Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free public preview Track ACIU with free AI briefings, catalyst countdowns, and dilution alerts.

ACIU — AC Immune SA

FDA catalysts, PDUFA dates with approval probability, drug pipeline, cash runway and insider activity — updated automatically from SEC, FDA and ClinicalTrials.gov data.

$91.4M Cash on Hand

15.8mo Cash Runway

6.3% Short Interest

🧪 Upcoming Trial Catalysts

2026-08-01 · Phase 1 — Recruiting — A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune Sy
2026-11-01 · EARLY_Phase 1 — Recruiting — [18F]ACI-19626 PET in TDP-43 Proteinopathies
2028-01-01 · Phase 2 — Active Trial — A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson

📊 Drug Pipeline

Drug	Indication	Phase	Status
ACI-7104.056 at Dose C (optional)	Parkinson Disease	PHASE2	ACTIVE_NOT_RECRUITING
ACI-7104.056 at Dose B (optional)	Parkinson Disease	PHASE2	ACTIVE_NOT_RECRUITING
ACI-7104.056 at Dose A	Parkinson Disease	PHASE2	ACTIVE_NOT_RECRUITING
ACI-24	Down Syndrome	PHASE2	WITHDRAWN
ACI-24 high dose	Down Syndrome	PHASE1	COMPLETED
JACI-35.054	Alzheimer's Disease	PHASE1	COMPLETED
ACI-35.030	Alzheimer's Disease	PHASE1	COMPLETED
ACI-24.060 at Dose D	Amyloid Plaque	PHASE1	RECRUITING
ACI-24.060 at Dose C	Amyloid Plaque	PHASE1	RECRUITING
ACI-24.060 at Dose B	Amyloid Plaque	PHASE1	RECRUITING

💰 Cash Runway & Dilution Risk

ACIU holds $91.4M in cash and burns about $17.3M/quarter from operations, giving an estimated runway of 15.8 months.

Source: SEC EDGAR XBRL (operating cash flow). Get dilution alerts for ACIU free →

Get the full ACIU picture

A free BioRadar account adds AI daily briefings, sentiment tracking, trial enrollment progress, and email alerts for ACIU and 2 more tickers of your choice.

Create Free Account →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z